Eli Lilly and Company (LLY) Financials

LLY Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 116.6 billion 85.4 billion
Dec. 31, 2025 112.5 billion 85.9 billion
Sept. 30, 2025 114.9 billion 91.1 billion
June 30, 2025 100.9 billion 82.6 billion

LLY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 3.0 billion 161.0 million
Dec. 31, 2025 677.9 million 136.1 million
Sept. 30, 2025 8.6 billion 151.1 million
June 30, 2025 1.3 billion 185.1 million

LLY Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 7.4 billion
Dec. 31, 2025 6.6 billion
Sept. 30, 2025 5.6 billion
June 30, 2025 5.7 billion

LLY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 5.3 billion 39.4 billion -
Dec. 31, 2025 7.3 billion 40.9 billion -
Sept. 30, 2025 9.9 billion 40.9 billion -
June 30, 2025 3.5 billion 34.2 billion -

LLY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 895.9 million
Dec. 31, 2025 898.0 million
Sept. 30, 2025 898.8 million
June 30, 2025 899.8 million

LLY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 2.3 billion 3.5 billion 2.9 billion 2.9 billion
Dec. 31, 2025 2.5 billion 3.8 billion 3.3 billion -
Sept. 30, 2025 223.9 million 3.5 billion 2.7 billion -
June 30, 2025 1.8 billion 3.3 billion 2.6 billion -

LLY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 19.8 billion 3.6 billion
Dec. 31, 2025 19.3 billion 2.9 billion
Sept. 30, 2025 17.6 billion 3.0 billion
June 30, 2025 15.6 billion 2.4 billion

LLY Revenue by Segment
Graph available only for paid members. Upgrade to see it.

LLY

List: Contenders

Price: $1,133

52 week price:
623.78
1166.29

Dividend Yield: 0.61%

5-year range yield:
0.61%
1.79%

Forward Dividend Yield: 0.61%

Payout Ratio: 63.73%

Payout Ratio Range:
-16062.50%
328.65%

Dividend Per Share: 6.92 USD

Earnings Per Share: 28.18 USD

P/E Ratio: 35.03

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United States

Volume: 2.6 million

Ebitda: 758.9 million

Market Capitalization: 1.1 trillion

Average Dividend Frequency: 4

Years Paying Dividends: 55

DGR3: 16.91%

DGR5: 16.13%

DGR10: 11.60%

DGR20: 7.34%

Links: